Takeda Pharmaceuticals U.S.A., Inc.: all contributions
2025–2026 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to Takeda Pharmaceuticals U.S.A., Inc.Showing the last prepared contribution list. Updated records are not ready.
| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 21 | MARTIN, HEATHERCAMBRIDGEMA02142 | HEAD OF GLOBAL MARKET ACCESS STRATEGYTAKEDA PHARMACEUTICALS U.S.A. INC. | TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEEC00441733 | 2026-08-31 | $30 | Primary (P) | P/R DEDUCTION ($15.00 BI-WEEKLY)Filing 2011921FEC filing ↗ |
| 22 | ZEVALLOS, KARLA NCAMBRIDGEMA02142 | GLOBAL TRG SR. MANAGERTAKEDA PHARMACEUTICALS U.S.A. INC. | TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEEC00441733 | 2026-08-31 | $30 | Primary (P) | P/R DEDUCTION ($15.00 BI-WEEKLY)Filing 2011921FEC filing ↗ |
| 23 | CARY, ZACHARY DCAMBRIDGEMA |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.